Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
CUI: C0023211
Disease: Left Bundle-Branch Block
Left Bundle-Branch Block
0.100 GeneticVariation BEFREE Improvement of CCS was similarly observed after aCRT and echo-guided BiV in CRT recipients with moderately wide LBBB and normal AV conduction. 31492516

2019

Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
CUI: C0023211
Disease: Left Bundle-Branch Block
Left Bundle-Branch Block
0.100 Biomarker BEFREE In conclusion, we computationally predicted and quantified that the CRT + LVAD implementation is superior to CRT-only implementation particularly in HF with LBBB condition. 30538769

2018

Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
CUI: C0023211
Disease: Left Bundle-Branch Block
Left Bundle-Branch Block
0.100 Biomarker BEFREE The aim of this study is to examine the relationship of the LV contraction pattern and the response of CRT in patients with left bundle branch block (LBBB). 28608184

2018

Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
CUI: C0023211
Disease: Left Bundle-Branch Block
Left Bundle-Branch Block
0.100 GeneticVariation BEFREE The effects of CRT-D versus an implantable cardioverter-defibrillator (ICD) alone to reduce long-term mortality were assessed in patients with left bundle branch block with DM (n = 386) and without DM (n = 982), enrolled in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT). 29625702

2018

Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
CUI: C0023211
Disease: Left Bundle-Branch Block
Left Bundle-Branch Block
0.100 Biomarker BEFREE In modern practice, the use of CRT in non-LBBB patients remains controversial, with high rates of non-response for CRT in patients with RBBB, in particular. 29064041

2017

Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
CUI: C0023211
Disease: Left Bundle-Branch Block
Left Bundle-Branch Block
0.100 Biomarker BEFREE Improvements in both survival and heart failure hospitalizations with CRT-D were greatest in patients with a QRSD ≥180 ms with or without LBBB, whereas patients with a QRSD 150 to 179 ms without LBBB had no improvement in survival with CRT-D, and those with a QRSD 150 to 179 ms and LBBB had only a modest improvement. 28427578

2017

Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
CUI: C0023211
Disease: Left Bundle-Branch Block
Left Bundle-Branch Block
0.100 Biomarker BEFREE Adaptive CRT in patients with normal AV conduction and left bundle branch block: Does QRS duration matter? 28416247

2017

Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
CUI: C0023211
Disease: Left Bundle-Branch Block
Left Bundle-Branch Block
0.100 GeneticVariation BEFREE Five-hundred thirty-four patients with LBBB in the CRT-D arm were followed for 5.6 years (median). 28688704

2017

Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
CUI: C0023211
Disease: Left Bundle-Branch Block
Left Bundle-Branch Block
0.100 Biomarker BEFREE The maximum LVED was recorded in mid-basal anterolateral or inferolateral LV segments (traditional CRT targets), significantly more often in patients with LBBB than in patients without LBBB (85% vs 59%; P = .02). 27989791

2017

Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
CUI: C0023211
Disease: Left Bundle-Branch Block
Left Bundle-Branch Block
0.100 Biomarker BEFREE However, CRT-D was increasingly more effective in reducing ACM hazard in patients with longer baseline PR intervals (P = 0.002) regardless of LBBB status. 27885751

2017